Immunization and Vaccines related Implementation Research Advisory Committee Meeting
25-26 September 2012, Geneva, Switzerland
In 2007 WHO's Department of Immunization, Vaccines, and Biologicals established the advisory group on Quantitative Immunization and Vaccines Related Research (QUIVER), with the main responsibility of reviewing quantitative methods in vaccine related research and to advise the Department of Immunization, Vaccines and Biologicals (IVB) on their relevance and applicability.
Given the importance of implementation research in immunization, the Department felt it necessary to enhance the functions of this advisory group to also include implementation research in addition to the existing functions of reviewing and advising on quantitative methods in vaccine research. Therefore, in the last meeting of QUIVER in October 2011, the proposal was endorsed and the Initiative for Vaccine Research (IVR) proceeded with the revision of the terms of reference and membership composition. Subsequently, the Advisory Group changed its name to Immunization and Vaccines related Implementation Research Advisory Committee (IVIR-AC).
The sixth annual meeting of the Advisory Committee took place from 25 to 26 September 2012. The purpose of this meeting was to review and propose recommendations on:
- the prioritization process and draft priority list for WHO immunization implementation research activities;
- the use of value of statistical life method for the Decade of Vaccines;
- Yellow Fever burden of disease (BoD);
- the WHO framework and related projects on the broader economic impact on vaccines and immunization programmes;
- Measles investment case for eradication;
- Costing of HPV vaccines;
- dynamic disease modelling component within the WHO GCEA model; and
- Varicella/Zoster (VZ) burden of disease estimation.